B.C.G. plus protease L in malignant melanoma.
D001500:BCG Vaccine / Q000009:adverse effects; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology; D008175:Lung Neoplasms / Q000276:immunology; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology*; D009163:Mycobacterium bovis; D010447:Peptide Hydrolases / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
D001500:BCG Vaccine; D010447:Peptide Hydrolases